A measure to expand federal financing for human embryonic stem cell research, passed by the House and once considered a shoo-in for adoption by the Senate, is tangled up in a procedural dispute that will probably delay a vote until fall - and could wind up killing the bill, its chief Republican backer said. "The bill is in some danger," said Representative Michael N. Castle, Republican of Delaware and the measure's leading sponsor in the House.